Percutaneous Coronary Intervention Market Overview
Percutaneous coronary intervention (PCI) refers to a family of minimally invasive procedures used to open clogged coronary arteries (those that deliver blood to the heart). By restoring blood flow, the treatment can improve symptoms of blocked arteries, such as chest pain or shortness of breath. The global Percutaneous Coronary Intervention market is projected to grow at a considerable rate in the coming years.
In recent years, the rise in the prevalence of heart disease has been regarded as one of the leading causes of death in both men and women. PCI is a procedure that is used to treat acute heart attacks, ease angina (chest discomfort), prevent heart attacks, and treat congestive heart failure, among other things. Because of the rising frequency of coronary heart disease, PCI has become increasingly important in recent years. According to World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2023, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
Over the forecast period, factors such as the rising frequency of cardiac disorders, the rising preference for minimally invasive procedures, and the growing geriatric population that is more sensitive to these diseases are expected to drive market expansion. However, the procedure's strict regulatory requirements may restrict the market's expansion.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Product Type, End User, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Abbott, ASAHI INTECC Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK, Boston Scientific Corporation, C. R. Bard, Inc., Comed BV, Cook, Cordis, Medtronic PLC, Meril Lifesciences Pvt. Ltd, Merit Medical System, Terumo Corporation. |
Covid-19 Impact on Percutaneous Coronary Intervention Market
In addition, the current Percutaneous Coronary Intervention Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Percutaneous Coronary Intervention Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Percutaneous Coronary Intervention Market Segment Overview
Based on Product Type, Coronary Stents is one of the major segments in the global Percutaneous Coronary Intervention market. A coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. It is used in a procedure called percutaneous coronary intervention (PCI). Coronary stents are now used in more than 90% of PCI procedures.
Percutaneous Coronary Intervention Market, By Product Type
· Coronary Stents
· PTCA Catheters
· Coronary Guidewire
· Accessories
Percutaneous Coronary Intervention Market, By End User
· Hospitals & Specialty Clinics
· Ambulatory Surgical Centers
· Research and Academic Institutes
· Others
Percutaneous Coronary Intervention Market Regional Overview
The global Percutaneous Coronary Intervention market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share in the global Percutaneous Coronary Intervention market. It is predicted that this region shows remarkable growth in the estimated period. This is primarily due to the mounting awareness and the growing acceptability of percutaneous coronary intervention techniques. Europe is the second-largest region for the market. The factors responsible for market growth in this region are an increased number of hospitalizations for percutaneous coronary intervention techniques such as carotid artery angioplasty and cerebral angioplasty. Moreover, the market in the Asia Pacific is projected to grow at a considerable rate in the coming years. This is due to the growing prevalence of cardiovascular diseases coupled with developing healthcare infrastructure and rising disposable income.
Percutaneous Coronary Intervention Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Percutaneous Coronary Intervention Market, Key Players
· Abbott
· ASAHI INTECC Company Limited
· B. Braun Melsungen AG
· Biosensors International Group, Ltd
· BIOTRONIK
· Boston Scientific Corporation
· C. R. Bard, Inc.
· Comed BV
· Cook
· Cordis
· Medtronic PLC
· Meril Lifesciences Pvt. Ltd
· Merit Medical System
· Terumo Corporation
Q1. What are the driving factors for the global Percutaneous Coronary Intervention market?
Factors such as the rising frequency of cardiac disorders, the rising preference for minimally invasive procedures, and the growing geriatric population that is more sensitive to these diseases are expected to drive market expansion
Q2. What are the restraining factors for the global Percutaneous Coronary Intervention market?
The procedure's strict regulatory requirements may restrict the market's expansion
Q3. Which segment is projected to hold the largest share in the global Percutaneous Coronary Intervention Market?
Coronary Stents segment is projected to hold the largest share in the global Percutaneous Coronary Intervention Market.
Q4. Which region holds the largest share in the global Percutaneous Coronary Intervention market?
North America held the largest share in the global Percutaneous Coronary Intervention market
Q5. Which are the prominent players in the global Percutaneous Coronary Intervention Market?
Abbott, ASAHI INTECC Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK, Boston Scientific Corporation, C. R. Bard, Inc., Comed BV, Cook, Cordis, Medtronic PLC, Meril Lifesciences Pvt. Ltd, Merit Medical System, Terumo Corporation. are some key players in the global Percutaneous Coronary Intervention Market.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
